Medicus Pharma (MDCX) Debt Ratio (2025)

Medicus Pharma (MDCX) reported Debt Ratio of 0.52 for Q4 2025, down 23.3% quarter-over-quarter from 0.68 in Q3 2025.

Medicus Pharma (MDCX) Debt Ratio (2025) Analysis & Trends

Medicus Pharma has reported Debt Ratio for 1 years, with the latest figure at 0.52 in Q4 2025.

For the quarter ending Q4 2025, Debt Ratio changed N/A year-over-year to 0.52; the trailing twelve-month figure through Dec 2025 stood at 0.52 (changed N/A YoY), and the FY2025 full-year result was 0.52, changed N/A from the prior year.
Debt Ratio for Q4 2025 stood at 0.52, down from 0.68 in the prior quarter.
The five-year high for Debt Ratio was 0.68 in Q3 2025, with the low at 0.39 in Q2 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	-0.22
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	0.37
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	0.27
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	0.47
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	0.38
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	0.62
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	0.39
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	0.31
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	0.51
10	Medicus Pharma	6.05 Mn	6.15 Mn	-	0.52

Historic Data

Download Data

Date	Value
Dec 31, 2025	0.52
Sep 30, 2025	0.68
Jun 30, 2025	0.39